https://www.PR.com/ Latest news releases from PR.com for ChemImage Corporation. Sat, 18 Apr 2026 21:54:25 -0400 © 2026 PR.com 60 en-us https://www.PR.com/images/logo_white.jpg https://www.PR.com/ 68 69 PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles. https://www.pr.com/press-release/697793 Tue, 06 Dec 2016 08:00:00 -0500 ChemImage Sensor Systems announced that on November 1st, 2016, the Humboldt County Sheriff’s Office in Eureka, CA became the third installation site for ChemImage Sensor System’s VeroVision Mail Screener, a system that offers easy, objective, one-click detection of drugs concealed on or within mail. Just two days later, while the VeroVision Mail Screener was being used to routinely scan inmate mail, it [PR.com] https://www.pr.com/press-release/697793 ChemImage Corporation https://www.pr.com/press-release/257555 Wed, 25 Aug 2010 03:00:00 -0400 ChemImage Corporation recently reached an agreement with Light Ace HK LTD, a China-based distributor of laboratory equipment, instrumentation and services, to offer the Falcon II Wide-Field Raman Chemical Imaging System and select analytical contract services in China. “This agreement affirms the value chemical imaging can bring to the international marketplace,” said Jim McGlone, president at ChemImage. [PR.com] https://www.pr.com/press-release/257555 ChemImage Corporation https://www.pr.com/press-release/255031 Wed, 11 Aug 2010 14:31:41 -0400 A study conducted by scientists at ChemImage Corporation, in partnership with a well-known U.S. medical research and treatment center, revealed that Raman Molecular Imaging (RMI), a type of hyperspectral imaging, has potential in predicting the progression of prostate cancer. Blinded samples from 38 patients with Gleason score 7 prostate cancer were evaluated using RMI, an emerging technology that combines digital [PR.com] https://www.pr.com/press-release/255031 ChemImage Corporation https://www.pr.com/press-release/248626 Thu, 15 Jul 2010 03:00:00 -0400 ChemImage’s 106th patent acknowledges Raman Molecular Imaging (RMI) as a way to assess similar-looking tissue samples in the diagnosing of renal disease tissue. [PR.com] https://www.pr.com/press-release/248626 ChemImage Corporation